
Design Therapeutics, Inc.
Design Therapeutics, Inc. (DSGN)
WebsitePrice
Market cap
Next catalystExpected Q1 2027DT-216P2 — RESTORE-FA · Phase 1/2 dataCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved